The Healthcare Businesswomen’s Association (HBA) today announced that it has named Kevin Rigby, vice president of public affairs at Novartis Pharmaceuticals Corporation and US country head of public affairs, as its 2013 Honorable Mentor. He will be formally recognized at the 24rd annual HBA Woman of the Year (WOTY) event in New York City, on Thursday, May 9, 2013 – the premier event of the year for the healthcare community, attended by over 2,500 industry leaders.
“This is such an incredible honor and it is humbling to be recognized for something that means so much to me. I am truly passionate about the power of mentoring, connecting and supporting one another,” said Rigby. “It is so inspiring to help people develop, grow and achieve their dreams. Receiving this prestigious award offers me the opportunity to encourage others to share their wisdom and make mentoring part of who we are and how we work.”
Created in 2001, the Honorable Mentor award recognizes one individual each year who demonstrates long-term support for the advancement of women in the healthcare industry, has a personal dedication to developing, mentoring and promoting women in the industry, and who has been supportive of the HBA’s goals.
“His intuition, optimism, sense of humor and willingness to provide honest, constructive feedback -- combined with his skills as an active listener and strategic thinker -- make Kevin a sought after mentor, counselor and confidante to a broad group of individuals,” said André Wyss, president of Novartis Corporation and Novartis Pharmaceuticals Corporation. “Kevin is passionate about diversity and inclusion and strongly supports the career development and advancement of associates across our organization.”
In addition to being vice president of public affairs for Novartis Pharmaceuticals Corporation and US country head of public affairs, he also serves on Novartis Corporation’s Country executive committee and as president of Novartis Patient Assistance Foundation Inc.
Coordinating the public affairs function across all Novartis US divisions, Kevin is focused on government interactions and corporate participation in the public policy arena at the federal and state levels. He also is responsible for Novartis Pharmaceuticals Corporation’s philanthropic contributions; programs for the uninsured and under-insured; interactions with state elected officials, patient groups, trade associations, and non-profit charitable organizations; and public policy initiatives.
Kevin is chairman of the HealthCare Institute of New Jersey, chair of the New Jersey Workplace Blood Donor Coalition, and board secretary of Choose New Jersey. He also serves as vice chair of the board of the Alliance for Aging Research and is past chair of the board for the National Pharmaceutical Council.